5-hydroxytryptamine receptor 3D

BE0009585ProteinHumansHTR3D

Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons. It is acted on by 1 drug in DrugBank.

Gene name
HTR3D
UniProtKB entry
Q70Z44Swiss-Prot
Cellular location
Postsynaptic cell membrane
Residues / weight
454 residues · 50,191 Da
Also known as
5-HT3-D · 5-HT3D · Serotonin receptor 3D

Resolves to

Protein
UniProtQ70Z44UniProt name5HT3D_HUMAN
Gene
HGNCHGNC:24004NCBI Gene200909GeneCardsHTR3D
Pharmacology
KEGGhsa:200909
Drugs

What you can answer from here — as of August 08, 2024

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
5GO termsFunction, process and component, as structured annotations
Sign in
2Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on 5-hydroxytryptamine receptor 3D, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In